Effects of recent Virginia AIDS Drug Assistance Program policy changes on diabetes and hyperlipidemia control in people living with HIV
Objectives: To describe the impacts of Virginia AIDS Drug Assistance Program’s elimination of diabetes and hyperlipidemia medication on disease outcomes in people living with HIV. Methods: Data were collected on two groups of people living with HIV who were prescribed medications for diabetes and/or...
Main Authors: | Kathleen A McManus, Relana Pinkerton, Rebecca Dillingham |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-04-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/2050312114532809 |
Similar Items
-
Current Challenges to the United States’ AIDS Drug Assistance Program and Possible Implications of the Affordable Care Act
by: Kathleen A. McManus, et al.
Published: (2013-01-01) -
Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines
by: Peter Liu, et al.
Published: (2017-05-01) -
Erratum to: Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines
by: Peter Liu, et al.
Published: (2017-05-01) -
A Cross-Sectional Study on the Affordable Care Act from the Perspective of People Living with HIV: The Interplay between Knowledge, Stigma, Trust, and Attitudes
by: Christopher Kaperak, et al.
Published: (2020-01-01) -
Recent progress in the management of atherosclerosis and hyperlipidemia
by: M. V. Ezhov
Published: (2017-12-01)